News
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...
Varenicline helped teens and young adults quit nicotine vapes when provided in conjunction with brief cessation counseling, a ...
In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
13h
Stockhead on MSNHealth Check: Snore-buster Resmed says miracle diet drugs and tariffs no threat to growthAfter reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will ...
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...
Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss ...
BUFFALO, N.Y. — In January, Nicole Albanese, PharmD, clinical associate professor of pharmacy practice in the University at ...
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results